Hospitalizations during the use of rifaximin versus lactulose for the treatment of hepatic encephalopathy

We sought to compare frequency and duration of hepatic encephalopathy-related hospitalizations during rifaximin versus lactulose treatment. Hospitalizations, clinical efficacy data, and adverse events obtained from charts of 145 patients with hepatic encephalopathy who received lactulose (30 cc twic...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Digestive diseases and sciences 2007-03, Vol.52 (3), p.737-741
Hauptverfasser:	LEEVY, Carroll B, PHILLIPS, James A
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Antibacterial agents Antibiotics. Antiinfectious agents. Antiparasitic agents Biological and medical sciences Female Gastroenterology. Liver. Pancreas. Abdomen Gastrointestinal Agents - economics Gastrointestinal Agents - therapeutic use Hepatic Encephalopathy - drug therapy Hepatic Encephalopathy - economics Hospitalization Hospitalization - economics Hospitalization - statistics & numerical data Humans Lactulose - economics Lactulose - therapeutic use Length of Stay Liver Cirrhosis - complications Liver. Biliary tract. Portal circulation. Exocrine pancreas Male Medical sciences Middle Aged New Jersey Other diseases. Semiology Pharmacology. Drug treatments Rifamycins - economics Rifamycins - therapeutic use Rifaximin
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!